Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis

Cytokine

Volumn 48, Issue 3, 2009, Pages 273-279

  Rull, Anna ^a   Rodríguez, Fernando ^a   Aragonès, Gerard ^a   Marsillach, Judit ^a   Beltrán, Raúl ^a   Alonso Villaverde, Carlos ^a   Camps, Jordi ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Dietary cholesterol; LDLr deficient mice; Liver steatosis; MCP 1; Obesity

Indexed keywords

CHOLESTEROL; FAT DROPLET; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY LIVER; GENE EXPRESSION; IMMUNOREACTIVITY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; LIVER DISEASE; LIVER DYSFUNCTION; LIVER HOMOGENATE; LIVER PROTECTION; MALE; METABOLIC SYNDROME X; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALIA; MUS;

EID: 70350018324     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.08.006     Document Type: Article

References (32)

1. Targher G., Bertolini L., Padovani R., Poli F., Scala L., Zenari L., et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest 29 (2006) 55-60
2. Marshall S. The hexosamine signaling pathway: a new road to drug discovery. Curr Opin Endocrinol Diab 9 (2002) 160-167
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
4. Gerard C., and Rollins B.J. Chemokines and disease. Nat Immunol 2 (2001) 108-115
5. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
6. Tous M., Ferre N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., et al. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 340 (2006) 1078-1084
7. Kip1-independent pathway. Atherosclerosis 172 (2004) 31-38
8. Chen Y.L., Chang Y.J., and Jiang M.J. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Atherosclerosis 143 (1999) 115-123
9. Vergnes L., Phan J., Strauss M., Tafuri S., and Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278 (2003) 42774-42784
10. Tous M., Ferre N., Camps J., Riu F., and Joven J. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem 268 (2005) 53-58
11. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
12. Marsillach J., Bertran N., Camps J., Ferre N., Riu F., Tous M., et al. The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem 38 (2005) 1138-1140
13. Leifeld L., Dumoulin F.L., Purr I., Janberg K., Trautwein C., Wolff M., et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 199 (2003) 335-344
14. Haukeland J.W., Damas J.K., Konopski Z., Loberg E.M., Haaland T., Goverud I., et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44 (2006) 1167-1174
15. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2 (1998) 275-281
16. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 (1999) 773-778
17. Yu X., Dluz S., Graves D.T., Zhang L., Antoniades H.N., Hollander W., et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 89 (1992) 6953-6957
18. Coll B., Alonso-Villaverde C., and Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?. Clin Chim Acta 383 (2007) 21-29
19. Sabio G., Das M., Mora A., Zhang Z., Jun J., Ko H., et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322 (2008) 1539-1543
20. Imai J., Katagiri H., Yamada T., Ishigaki Y., Suzuki T., Kudo H., et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 322 (2008) 1250-1254
21. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 13 (2005) 1311-1320
22. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100 (2003) 7265-7270
23. Takahashi K., Mizuarai S., Araki H., Mashiko S., Ishihara A., Kanatani A., et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278 (2003) 46654-46660
24. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2 (2005) 92-100
25. Stienstra R., Duval C., Müller M., and Kersten S. PPARs, obesity, and inflammation. PPAR Res 2007 (2007) 95974
26. Marsillach J., Camps J., Ferré N., Beltran R., Rull A., Mackness B., et al. Paraoxonase-1 is related to inflammation, fibrosis, PPAR delta in experimental liver disease. BMC Gastroenterol 9 (2009) 3
27. Qin X., Xie X., Fan Y., Tian J., Guan Y., Wang X., et al. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 48 (2008) 432-441
28. Clément S., Juge-Aubry C., Sgroi A., Conzelmann S., Pazienza V., Pittet-Cuenod B., et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 48 (2008) 799-807
29. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278 (2003) 34268-34276
30. Sedlmeier E.M., Grallert H., Huth C., Lowel H., Herder C., Strassburger K., et al. Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg. Eur J Endocrinol 156 (2007) 377-385
31. Coll B., van Wijk J.P., Parra S., Castro Cabezas M., Hoepelman I.M., Alonso-Villaverde C., et al. Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. Eur J Pharmacol 544 (2006) 104-110
32. Rull A., Escolà-Gil J.C., Julve J., Rotllan N., Calpe-Berdiel L., Coll B., et al. Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism. Exp Mol Pathol 83 (2007) 361-366